Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

NCT01059071 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

NCT NCT01059071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01059071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Lead sponsor
Giselle Sholler
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2010
Completion date
May 31, 2015
Enrollment
21 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma